Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Inmune Bio (INMB) has issued an announcement.
INmune Bio Inc. has recently granted their CEO, Ramond J. Tesi, an option to buy 37,882 shares at $8.72 each as part of their 2021 Stock Incentive Plan. This option became effective immediately and is set to expire on June 9, 2034, demonstrating the company’s confidence in their leadership and providing an incentive for continued success.
For detailed information about INMB stock, go to TipRanks’ Stock Analysis page.